Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · IEX Real-Time Price · USD
26.76
-0.32 (-1.18%)
At close: Jul 19, 2024, 4:00 PM
26.81
+0.05 (0.19%)
Pre-market: Jul 22, 2024, 4:27 AM EDT
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $1.85 billion as of July 22, 2024. Its market cap has decreased by -17.95% in one year.
Market Cap
1.85B
Enterprise Value
982.37M
1-Year Change
-17.95%
Ranking
Category
Stock Price
$26.76
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $481.70M to $1.85B, an increase of 284.16%. That is a compound annual growth rate of 30.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.85B | 42.26% |
| Dec 29, 2023 | 1.30B | -49.24% |
| Dec 30, 2022 | 2.56B | 247.28% |
| Dec 31, 2021 | 737.90M | -17.63% |
| Dec 31, 2020 | 895.80M | 41.32% |
| Dec 31, 2019 | 633.90M | 31.60% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 1.90B |
| Warby Parker | 1.88B |
| Mirum Pharmaceuticals | 1.86B |
| Verona Pharma | 1.86B |
| NeoGenomics | 1.85B |
| Zai Lab | 1.85B |
| RxSight | 1.82B |
| Harmony Biosciences Holdings | 1.82B |